Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Our extensive expertise in product development has been built over the past 30 years—fueling the success of more than 10 widely recognized products. We are dedicated to the goal of improving the treatment of CNS disorders, including attention-deficit/hyperactivity disorder (ADHD), mood disorders, epilepsy, migraine and Parkinson’s disease.
Visit the Resources tab for full Prescribing Information, including Boxed Warning and Important Safety Information.
AAP Nat Con